Aim. Avidly phagocytosed hemozoin (malarial pigment) alters several functions of human monocytes and stimulates generation of several cytokines. Recently, we showed that phagocytosis of hemozoin by human monocytes increases expression and activity of matrix metalloproteinase-9, a proteolytic enzyme available in specific gelatinase granules, which contain several enzymes including lysozyme. Present work investigated active lysozyme release after phagocytosis of hemozoin and its dependence on production of tumor necrosis factor alpha. Methods. After phagocytosis of hemozoin, hemozoin-containing trophozoites or control meals (opsonized nonparasitized red blood cells and latex particles), monocyte supernatants were monitored for 2 hours, in presence of blocking anti-human tumor necrosis factor alpha antibodies or recombinant human tumor necrosis factor alpha cytokine in selected experiments. Lysozyme release was evaluated by a specific spectrometric assay measuring lysozyme activity after coincubation of cell supernatants with suspensions of Mycrococcus Lysodeikticus, while levels of soluble tumor necrosis factor alpha were analyzed by specific enzyme-linked immunodsorbent assay. Results. Levels of lysozyme activity and soluble tumor necrosis factor alpha protein were increased in hemozoin- or trophozoites-laden monocytes supernatants. Phagocytosis per se (control meals) also increased lysozyme release, but levels were significantly lower than those obtained after phagocytosis of hemozoin or trophozoites. Interestingly, all effects on lysozyme release observed after phagocytosis were abrogated by blocking anti-human tumor necrosis factor alpha antibodies, while they were mimicked by recombinant human tumor necrosis factor alpha cytokine. Conclusions. Present work shows that phagocytosis of hemozoin promotes monocyte degranulation and enhances active lysozyme release. The effect requires tumor necrosis factor alpha mediation.
Hemozoin triggers Tumor Necrosis Factor alpha-mediated release of lysozyme by human adherent monocytes: new evidences on leucocyte degranulation in P falciparum malaria
PRATO, Mauro;GIRIBALDI, Giuliana;ARESE, Paolo
2009-01-01
Abstract
Aim. Avidly phagocytosed hemozoin (malarial pigment) alters several functions of human monocytes and stimulates generation of several cytokines. Recently, we showed that phagocytosis of hemozoin by human monocytes increases expression and activity of matrix metalloproteinase-9, a proteolytic enzyme available in specific gelatinase granules, which contain several enzymes including lysozyme. Present work investigated active lysozyme release after phagocytosis of hemozoin and its dependence on production of tumor necrosis factor alpha. Methods. After phagocytosis of hemozoin, hemozoin-containing trophozoites or control meals (opsonized nonparasitized red blood cells and latex particles), monocyte supernatants were monitored for 2 hours, in presence of blocking anti-human tumor necrosis factor alpha antibodies or recombinant human tumor necrosis factor alpha cytokine in selected experiments. Lysozyme release was evaluated by a specific spectrometric assay measuring lysozyme activity after coincubation of cell supernatants with suspensions of Mycrococcus Lysodeikticus, while levels of soluble tumor necrosis factor alpha were analyzed by specific enzyme-linked immunodsorbent assay. Results. Levels of lysozyme activity and soluble tumor necrosis factor alpha protein were increased in hemozoin- or trophozoites-laden monocytes supernatants. Phagocytosis per se (control meals) also increased lysozyme release, but levels were significantly lower than those obtained after phagocytosis of hemozoin or trophozoites. Interestingly, all effects on lysozyme release observed after phagocytosis were abrogated by blocking anti-human tumor necrosis factor alpha antibodies, while they were mimicked by recombinant human tumor necrosis factor alpha cytokine. Conclusions. Present work shows that phagocytosis of hemozoin promotes monocyte degranulation and enhances active lysozyme release. The effect requires tumor necrosis factor alpha mediation.File | Dimensione | Formato | |
---|---|---|---|
prato APJTM 2009.pdf
Accesso riservato
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
1.06 MB
Formato
Adobe PDF
|
1.06 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.